A Medical Device Daily

Bracco Diagnostics (Princeton, New Jersey), a large provider of imaging agents, and HealthTrust Purchasing Group (HPG; Brentwood, Tennessee), a healthcare group purchasing organization, reported a three-year agreement, to make Bracco Imaging’s (Milan, Italy) MRI contrast media products available to HealthTrust members through 2010.

This agreement includes MultiHance (gadobenate dimeglumine) injection, 529 mg/mL and ProHance (gadoteridol) injection 279.3 mg/mL.

“We are very excited to expand our partnership with HealthTrust to include our MR portfolio. This agreement provides HealthTrust members access to high quality MR contrast media,” said Carlo Medici, president/CEO, Bracco Diagnostics.

Bracco is the U.S.-based subsidiary of Bracco Imaging, which is part of the Bracco Group (Milan, Italy).